SCHEMBL23793738

SCHEMBL23793738

CCCN1CC(Oc2cc(F)c(C3c4[nH]c5ccccc5c4CCN3CC(C)(C)F)c(F)c2)C1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21012130 1.00 ESR1 (0.73) ESR1
SCHEMBL23794112 0.92 ESR1 (0.74) ESR1
SCHEMBL17858901 0.88 ESR1 (0.62) ESR1
SCHEMBL21012023 0.87 ESR1 (0.58) ESR1
SCHEMBL23793705 0.87 ESR1 (0.58) ESR1
SCHEMBL21011957 0.85 ESR1 (0.56) ESR1
SCHEMBL17858935 0.85 ESR1 (0.67) ESR1
SCHEMBL17858907 0.85 ESR1 (0.66) ESR1
SCHEMBL25002345 0.85 ESR1 (1.00) ESR1
SCHEMBL17839138 0.85 ESR1 (1.00) ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3912680-A1 TETRAHYDRO-1H-PYRIDO[3,4-B]INDOLE ANTI-ESTROGENIC DRUGS Olema Pharmaceuticals, Inc. (US) 2021-11-24 — — EP disclosed
WO-2021178846-A1 METHODS OF TREATING ESTROGEN RECEPTOR-ASSOCIATED DISEASES OLEMA PHARMACEUTICALS, INC. (US) 2021-09-10 — — WO disclosed
Send feedback